RecruitingNCT05612100
Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients
Studying Alopecia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mayo Clinic
- Principal Investigator
- Elizabeth Cathcart-Rake, M.D., MDMayo Clinic in Rochester
- Intervention
- Electronic Health Record Review(other)
- Enrollment
- 170 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2022 – 2028
Study locations (23)
- Mayo Clinic Health System in Albert Lea, Albert Lea, Minnesota, United States
- Essentia Health Baxter Clinic, Baxter, Minnesota, United States
- Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States
- Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota, United States
- Essentia Health - Deer River Clinic, Deer River, Minnesota, United States
- Essentia Health Saint Mary's - Detroit Lakes Clinic, Detroit Lakes, Minnesota, United States
- Essentia Health Cancer Center, Duluth, Minnesota, United States
- Essentia Health Ely Clinic, Ely, Minnesota, United States
- Essentia Health - Fosston, Fosston, Minnesota, United States
- Fairview Grand Itasca Clinic & Hospital, Grand Rapids, Minnesota, United States
- Essentia Health Hibbing Clinic, Hibbing, Minnesota, United States
- Fairview Range Medical Center, Hibbing, Minnesota, United States
- Essentia Health - International Falls Clinic, International Falls, Minnesota, United States
- Mayo Clinic Health Systems-Mankato, Mankato, Minnesota, United States
- MMCORC CentraCare Monticello Cancer Center, Monticello, Minnesota, United States
- +8 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05612100 on ClinicalTrials.govOther trials for Alopecia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07533006A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)Eli Lilly and Company
- ENROLLING BY INVITATIONNCT07499713Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia AreataIstanbul Training and Research Hospital
- RECRUITINGPHASE3NCT07435012Androgenic Alopecia TH07 Clinical TrialTriple Hair Inc
- RECRUITINGNANCT07422376Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands RegionCharles Mays
- RECRUITINGNCT07226531Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the USPfizer
- RECRUITINGNANCT07563036JAK2 Expression in Androgenetic Alopecia Before and After Topical MinoxidilKasr El Aini Hospital
- RECRUITINGPHASE2NCT07370519Topical Application of Lactobacillus Reuteri for Androgenetic AlopeciaShenzhen People's Hospital
- ACTIVE NOT RECRUITINGNANCT07520019Study Evaluating the Effect of Nutra Harmony "Biotin, Collagen and Keratin Beauty Complex" Dietary Supplement on Hair Thickness and Hair Strength in Adults With Self-Perceived Thinning HairNutra Harmony LLC